• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunosuppression and SARS-CoV-2 breakthrough infections.

作者信息

Kim Alfred H J, Sparks Jeffrey A

机构信息

Division of Rheumatology, Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.

Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.

出版信息

Lancet Rheumatol. 2022 Jun;4(6):e379-e380. doi: 10.1016/S2665-9913(22)00127-8. Epub 2022 Apr 29.

DOI:10.1016/S2665-9913(22)00127-8
PMID:35527809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9054102/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/953f/9054102/c8ca14d5b0b3/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/953f/9054102/c8ca14d5b0b3/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/953f/9054102/c8ca14d5b0b3/fx1_lrg.jpg

相似文献

1
Immunosuppression and SARS-CoV-2 breakthrough infections.免疫抑制与新型冠状病毒2型突破性感染
Lancet Rheumatol. 2022 Jun;4(6):e379-e380. doi: 10.1016/S2665-9913(22)00127-8. Epub 2022 Apr 29.
2
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.加利福尼亚州旧金山湾区疫苗突破性病例中抗体耐药的 SARS-CoV-2 变异株占优势。
Nat Microbiol. 2022 Feb;7(2):277-288. doi: 10.1038/s41564-021-01041-4. Epub 2022 Jan 10.
3
Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers.接种疫苗的医护人员中突破性 SARS-CoV-2 感染的危险因素。
PLoS One. 2021 Oct 15;16(10):e0258820. doi: 10.1371/journal.pone.0258820. eCollection 2021.
4
Association of Psychiatric Disorders With Incidence of SARS-CoV-2 Breakthrough Infection Among Vaccinated Adults.接种疫苗的成年人中精神疾病与SARS-CoV-2突破性感染发生率的关联
JAMA Netw Open. 2022 Apr 1;5(4):e227287. doi: 10.1001/jamanetworkopen.2022.7287.
5
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.在意大利 Delta 和奥密克戎变异株流行期间，接受疾病修正治疗的多发性硬化症患者在感染 COVID-19 后突破性感染 SARS-CoV-2。
EBioMedicine. 2022 Jun;80:104042. doi: 10.1016/j.ebiom.2022.104042. Epub 2022 May 5.
6
Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021.疫苗接种后，熟练护理机构居民和工作人员中的 SARS-CoV-2 感染 - 伊利诺伊州芝加哥，2020 年 12 月至 2021 年 3 月。
MMWR Morb Mortal Wkly Rep. 2021 Apr 30;70(17):632-638. doi: 10.15585/mmwr.mm7017e1.
7
SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May-June 2021.2021 年 5 月至 6 月期间，美国驻乌干达大使馆工作人员中出现的 SARS-CoV-2 突破感染。
Emerg Infect Dis. 2022 Jun;28(6):1279-1280. doi: 10.3201/eid2806.220427. Epub 2022 Apr 26.
8
A case report of breakthrough infection with the SARS-CoV-2 delta variant and household transmission: Role of vaccination, anti-spike IgG and neutralizing activity.SARS-CoV-2 德尔塔变异株突破性感染及家庭传播病例报告：疫苗接种、抗刺突 IgG 及中和活性的作用。
J Infect Chemother. 2022 Jul;28(7):962-964. doi: 10.1016/j.jiac.2022.02.003. Epub 2022 Feb 11.
9
Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population.高危国家人群接种疫苗后出现严重急性呼吸综合征冠状病毒2型突破性感染患者的结局。
EClinicalMedicine. 2021 Aug 28;40:101117. doi: 10.1016/j.eclinm.2021.101117. eCollection 2021 Oct.
10
Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination.接种疫苗后出现突破性SARS-CoV-2感染患者的结局
Int J Infect Dis. 2021 Sep;110:353-358. doi: 10.1016/j.ijid.2021.08.008. Epub 2021 Aug 8.

引用本文的文献

1
Decoding Immuno-Competence: A Novel Analysis of Complete Blood Cell Count Data in COVID-19 Outcomes.解码免疫能力：对新冠病毒疾病结局中全血细胞计数数据的新分析
Biomedicines. 2024 Apr 15;12(4):871. doi: 10.3390/biomedicines12040871.
2
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments.接受积极抗肿瘤治疗的癌症患者接种第三剂和第四剂BNT162b2疫苗的反应率
Diseases. 2023 Sep 26;11(4):128. doi: 10.3390/diseases11040128.
3
The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic.

本文引用的文献

1
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.使用免疫抑制剂的免疫介导炎症性疾病的接种疫苗患者中出现的德尔塔（B.1.617.2）变异株导致的严重急性呼吸综合征冠状病毒2突破性感染：两项前瞻性队列研究的子研究
Lancet Rheumatol. 2022 Jun;4(6):e417-e429. doi: 10.1016/S2665-9913(22)00102-3. Epub 2022 Apr 29.
2
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.接种疫苗的风湿病患者中出现的SARS-CoV-2突破性感染：来自COVID-19全球风湿病联盟提供者登记处的结果。
RMD Open. 2022 Apr;8(1). doi: 10.1136/rmdopen-2021-002187.
3
免疫抑制在新冠病毒疾病住院治疗中的作用：三年新冠病毒疫情期间的临床和流行病学趋势
Front Med (Lausanne). 2023 Sep 7;10:1260950. doi: 10.3389/fmed.2023.1260950. eCollection 2023.
4
A Pictorial Essay Describing the CT Imaging Features of COVID-19 Cases throughout the Pandemic with a Special Focus on Lung Manifestations and Extrapulmonary Vascular Abdominal Complications.一篇图文并茂的文章，描述了新冠疫情期间新冠肺炎病例的CT成像特征，特别关注肺部表现和肺外血管腹部并发症。
Biomedicines. 2023 Jul 26;11(8):2113. doi: 10.3390/biomedicines11082113.
5
Characteristics of COVID-19 vaccinated and unvaccinated patients admitted to Careggi University Hospital, Florence, Italy.意大利佛罗伦萨卡雷吉大学医院收治的 COVID-19 疫苗接种者和未接种疫苗者的特征。
Intern Emerg Med. 2023 Apr;18(3):821-830. doi: 10.1007/s11739-023-03231-w. Epub 2023 Feb 28.
6
COVID-19 Vaccination in Patients with Chronic Liver Disease.慢性肝病患者的 COVID-19 疫苗接种。
Viruses. 2022 Dec 13;14(12):2778. doi: 10.3390/v14122778.
7
Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA.接种疫苗后抗 SARS-CoV-2 中和抗体滴度可预测 RA 患者 24 周内的抗 S IgG 水平。
RMD Open. 2022 Oct;8(2). doi: 10.1136/rmdopen-2022-002575.
Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort.接种疫苗后的抗体滴度可预测自身免疫性疾病患者对 COVID-19 的保护作用：前瞻性队列研究中的生存分析。
Ann Rheum Dis. 2022 Jun;81(6):868-874. doi: 10.1136/annrheumdis-2021-221922. Epub 2022 Feb 8.
4
Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US.美国 SARS-CoV-2 疫苗接种后免疫功能障碍与 COVID-19 突破性感染的关联。
JAMA Intern Med. 2022 Feb 1;182(2):153-162. doi: 10.1001/jamainternmed.2021.7024.
5
SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases.炎症性风湿性和肌肉骨骼疾病患者接种疫苗后感染新型冠状病毒2型
Ann Rheum Dis. 2022 Jan;81(1):145-150. doi: 10.1136/annrheumdis-2021-221217. Epub 2021 Sep 6.
6
Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases.接种疫苗的系统性自身免疫性风湿病患者中新冠病毒突破性感染的临床特征与结局
Ann Rheum Dis. 2022 Feb;81(2):289-291. doi: 10.1136/annrheumdis-2021-221326. Epub 2021 Sep 6.
7
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study.免疫抑制对SARS-CoV-2 mRNA疫苗免疫原性的影响：一项前瞻性队列研究。
Ann Intern Med. 2021 Nov;174(11):1572-1585. doi: 10.7326/M21-1757. Epub 2021 Aug 31.
8
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies.荷兰自身免疫性疾病患者接种新冠疫苗后的抗体产生情况：两项前瞻性队列研究数据的子研究
Lancet Rheumatol. 2021 Nov;3(11):e778-e788. doi: 10.1016/S2665-9913(21)00222-8. Epub 2021 Aug 6.
9
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.生物制剂或靶向合成 DMARDs 的基线使用与类风湿关节炎 COVID-19 严重程度的相关性：来自 COVID-19 全球风湿病联盟医生登记处的结果。
Ann Rheum Dis. 2021 Sep;80(9):1137-1146. doi: 10.1136/annrheumdis-2021-220418. Epub 2021 May 28.